Biblio
Export 327 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is I [Clear All Filters]
“Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 2, pp. 653-680, 2018.
, “A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 193-205, 2018.
, “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
, “Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 2, pp. 465-474, 2018.
, “Social Dysfunction in Older Age and Relationships with Cognition, Depression, and Apathy: The GreatAGE Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 989-1000, 2018.
, “Structural Anatomical Investigation of Long-Term Memory Deficit in Behavioral Frontotemporal Dementia.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1887-1900, 2018.
, “Subjective Sleep Quality is not Associated with Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 239-247, 2018.
, “Subjective Sleep Quality is not Associated with Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 239-247, 2018.
, “Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1587-1597, 2018.
, “Three Decades of Dementia Research: Insights from One Small Community of Indomitable Rotterdammers.”, J Alzheimers Dis, vol. 64, no. s1, pp. S145-S159, 2018.
, “Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 64, no. 1, pp. 249-267, 2018.
, “Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1485-1497, 2018.
, “TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1275-1284, 2018.
, “Vascular Effects on Depressive Symptoms in Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 597-605, 2018.
, “Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1539-1548, 2018.
, “A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1459-1468, 2017.
, “Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
, “Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 615-631, 2017.
, “Aortic Valve Calcification and the Risk of dementia: A Population-Based Study.”, J Alzheimers Dis, vol. 55, no. 3, pp. 893-897, 2017.
, “Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1151-1161, 2017.
, “Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1151-1161, 2017.
, “Association between Mid-Regional Proadrenomedullin Levels and Progression of Deep White Matter Lesions in the Brain Accompanying Cognitive Decline.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1253-1262, 2017.
, “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
, “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
, “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
,